Literature DB >> 35967261

Substance Use Disorder Treatment Providers' Knowledge and Opinions Toward Testing and Treatment of Chronic Hepatitis C in Rural North Carolina.

Donna M Evon1, Christopher B Hurt2, Delesha M Carpenter3, Sarah K Rhea4, Caitlin M Hennessy4, William A Zule4.   

Abstract

Poor access to care has made western North Carolina vulnerable to an outbreak of hepatitis C viral infection (HCV), particularly among persons who inject drugs (PWID). As substance use disorder (SUD) treatment providers could potentially improve linkage to HCV testing and treatment, we sought to understand SUD providers, clinic and client characteristics; referral patterns; HCV knowledge; willingness to participate in additional trainings; and local linkage-to-care pathways for treatment of substance use and HCV. Online survey data were collected from 78 SUD providers serving PWID in eight western rural North Carolina counties. Providers' attitudes toward working with HCV+ clients were very positive. One-third of providers reported a low fund of knowledge regarding HCV, HCV treatment, and financial assistance opportunities. Non-prescribing providers rarely initiated discussions about HCV testing/treatment, but were receptive to training. Respondents indicated that HCV testing and treatment were best delivered at local health departments or primary care clinics but were open to other venues where PWID access care. The vast majority of prescribing and non-prescribing providers expressed interest in obtaining training in HCV treatments, how to obtain HCV medications and topics on advanced liver disease. Data from prescribing and non-prescribing SUD providers suggest opportunities to develop or expand integrated care models for HCV testing/treatment in PWID in rural Appalachian North Carolina.

Entities:  

Keywords:  hepatitis C virus; injection drug use; opioid; questionnaire; survey

Year:  2022        PMID: 35967261      PMCID: PMC9371459          DOI: 10.1037/rmh0000200

Source DB:  PubMed          Journal:  Rural Ment Health        ISSN: 1935-942X


  33 in total

1.  Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Lan Jiang
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

2.  HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users.

Authors:  Jennifer C Elliott; Deborah S Hasin; Malka Stohl; Don C Des Jarlais
Journal:  AIDS Behav       Date:  2016-03

3.  America's Declining Well-Being, Health, and Life Expectancy: Not Just a White Problem.

Authors:  Peter A Muennig; Megan Reynolds; David S Fink; Zafar Zafari; Arline T Geronimus
Journal:  Am J Public Health       Date:  2018-09-25       Impact factor: 9.308

4.  Health professionals' attitudes toward caring for people with hepatitis C.

Authors:  J A Richmond; T L Dunning; P V Desmond
Journal:  J Viral Hepat       Date:  2007-09       Impact factor: 3.728

5.  Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users.

Authors:  William A Zule; Christine Oramasionwu; Donna Evon; Sayaka Hino; Irene A Doherty; Georgiy V Bobashev; Wendee M Wechsberg
Journal:  Am J Drug Alcohol Abuse       Date:  2016-06-10       Impact factor: 3.829

6.  Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study.

Authors:  Alain H Litwin; John Jost; Katherine Wagner; Moonseong Heo; Alison Karasz; Judith Feinberg; Arthur Y Kim; Paula J Lum; Shruti H Mehta; Lynn E Taylor; Judith I Tsui; Irene Pericot-Valverde; Kimberly Page
Journal:  Contemp Clin Trials       Date:  2019-10-24       Impact factor: 2.226

Review 7.  Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review.

Authors:  Viktor Mravčík; Lisa Strada; Josef Stolfa; Vladimir Bencko; Teodora Groshkova; Jens Reimer; Bernd Schulte
Journal:  Patient Prefer Adherence       Date:  2013-10-17       Impact factor: 2.711

8.  Hepatitis C virus knowledge improves hepatitis C virus screening practices among primary care physicians.

Authors:  Sandeep T Samuel; Anthony D Martinez; Yang Chen; Marianthi Markatou; Andrew H Talal
Journal:  World J Hepatol       Date:  2018-02-27

9.  Hepatitis C treatment uptake among people who inject drugs in the oral direct-acting antiviral era.

Authors:  Oluwaseun Falade-Nwulia; Rachel E Gicquelais; Jacquie Astemborski; Sean D McCormick; Greg Kirk; Mark Sulkowski; David L Thomas; Shruti H Mehta
Journal:  Liver Int       Date:  2020-10       Impact factor: 8.754

10.  Neglected infections of poverty in the United States of America.

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2008-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.